ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 127 filers reported holding ARCELLX INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,098,719 | -27.1% | 643,777 | -35.8% | 2.13% | -39.5% |
| Q2 2023 | $31,683,208 | -17.6% | 1,001,999 | -19.7% | 3.52% | -11.6% |
| Q1 2023 | $38,455,409 | +12.6% | 1,248,147 | +13.2% | 3.98% | -18.7% |
| Q4 2022 | $34,153,808 | +46.8% | 1,102,447 | -11.1% | 4.90% | +55.0% |
| Q3 2022 | $23,273,000 | +41.5% | 1,239,913 | +36.3% | 3.16% | +23.2% |
| Q2 2022 | $16,448,000 | +18.5% | 909,739 | -8.1% | 2.57% | +43.4% |
| Q1 2022 | $13,876,000 | – | 989,739 | – | 1.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $141,605,084 | 72.57% |
| NEA Management Company, LLC | 3,745,262 | $134,380,001 | 10.38% |
| Paradigm Biocapital Advisors LP | 2,953,122 | $105,958,017 | 7.19% |
| Samsara BioCapital, LLC | 613,921 | $22,027,485 | 6.74% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,869,967 | $102,974,416 | 5.56% |
| Perceptive Advisors | 3,965,978 | $142,299,291 | 4.75% |
| Cormorant Asset Management, LP | 2,150,000 | $77,142,000 | 4.50% |
| Affinity Asset Advisors, LLC | 400,000 | $14,352,000 | 4.04% |
| Novo Holdings A/S | 1,075,000 | $38,571,000 | 2.85% |
| Soleus Capital Management, L.P. | 643,777 | $23,098,719 | 2.13% |